Management of Turner Syndrome
Turner syndrome management requires a comprehensive approach focusing on cardiovascular surveillance, growth hormone therapy, estrogen replacement, and screening for associated conditions to reduce morbidity and mortality.
Cardiovascular Management
Cardiovascular complications are a major concern in Turner syndrome due to increased risk of aortic dissection:
Initial Evaluation:
Surveillance Protocol:
Surgical Intervention:
Growth Management
- Growth hormone therapy is standard treatment for short stature 3, 4, 5
- Start early when growth velocity decreases or height falls below the 5th percentile 5
- Monitor for potential side effects including glucose intolerance 6
Hormonal Management
- Estrogen replacement therapy typically initiated around age 11-12 years 4, 5
- Start with low doses and gradually increase to adult replacement levels 5
- Continued through normal menopausal age to prevent osteoporosis and cardiovascular disease 4, 5
Additional Screening and Management
Endocrine:
Other Systems:
Transition and Adult Care
- Structured transition from pediatric to adult care is critical 2, 4, 5
- Adult follow-up should continue lifelong due to ongoing risks 2, 6
- Multidisciplinary approach involving endocrinology, cardiology, gynecology, and other specialties as needed 6
Emergency Considerations
- Any sudden, severe chest or abdominal pain should prompt immediate evaluation for aortic dissection 2
- Strict blood pressure control and surgical consultation essential if dissection suspected 2
Pregnancy Considerations
- Pre-pregnancy cardiovascular assessment mandatory 1, 2
- High-risk pregnancy requiring specialized care 2
- Oocyte donation may be an option for women with ovarian failure 5
Turner syndrome requires lifelong surveillance with particular attention to cardiovascular health, as aortic dissection represents a significant mortality risk that can be mitigated through appropriate monitoring and timely intervention.